Marico Q1 FY26 revenue rose 23%, profit grew 8%; lifted Plix stake to 60% (resurfacing early-August update)
Marico reported Q1 FY26 revenue of Rs 3,259 crore, up 23.3% year-on-year, while consolidated net profit rose 8.2% to Rs 513 crore, per an update from August 4, 2025 resurfacing now. India revenue grew 27.2%, and the company increased its fully diluted stake in Plix maker Satiya Nutraceuticals to 60%.
What happened
Marico posted strong Q1 FY26 growth, led by India core portfolios, foods and digital-first products. It raised its stake in Plix maker Satiya Nutraceuticals to
Key facts
- Q1 FY26 consolidated net profit: Rs 513 crore, up 8.2% YoY
- Revenue from operations: Rs 3,259 crore, up 23.31% YoY
- India revenue: Rs 2,495 crore, up 27.17% YoY
- International revenue: Rs 764 crore, up 12.91% YoY
- Marico increased stake in Satiya Nutraceuticals/Plix to 60% fully diluted
Why this matters
Raising the fully diluted Plix stake to 60% strengthens Marico’s position in nutrition and wellness, signaling a deeper commitment to scaling adjacent premium consumer-health platforms.
What to watch
- Sequential India volume growth versus pricing-led growth.
- Copra, edible oil, crude derivatives and packaging-material cost trends.
- Gross margin and EBITDA margin movement relative to revenue growth.
- Rural demand recovery and competitive pricing actions in coconut oil and value-added hair oils.
- Plix revenue growth, distribution expansion, repeat purchase metrics and integration-related costs.
- Advertising and promotion spending as a percentage of sales.
- Any further acquisitions or stake increases in digital-first health, wellness or nutrition brands.
- Expand Plix products into Marico's general trade, modern trade and international distribution network while retaining a direct-to-consumer growth channel.
- Increase marketing and innovation spending in health, nutrition, premium personal care and food categories to diversify beyond core coconut oil.
- Use price-pack architecture and calibrated price hikes to offset commodity inflation without weakening rural demand.
- Pursue operational integration with Satiya Nutraceuticals, including procurement, manufacturing, compliance and distribution synergies.
- Provide guidance on gross-margin trajectory, advertising intensity and the timeline for Plix profitability contribution.